Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in development is designed to induce a powerful immune response to melanoma.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Since 1980, 83 percent of gains in life expectancy for cancer patients have been attributable to new treatments.  
  • Gains in healthy years of life and social value from cancer R&D
     
  • “If you had been diagnosed with chronic myeloid leukemia (CML) in 1999, chances were that you would not be alive today. Just 3 out of 10 patients survived for…  
  • Death rates from breast cancer declined by an average of 2.3% per year between 1990 and 2002 because of earlier detection through screening, better awareness, and improved treatments.  
  • Following the current path, breast cancer incidence rate will increase by 50.8% between 2003 and 2023. If an alternative path is taken, cases will increase by 32.2% between 2003 and…